Can Cisplatin Therapy Be Improved? Pathways That Can Be Targeted
<div><p>Cisplatin (cis-diamminedichloroplatinum (II)) is the oldest known chemotherapeutic agent. Since the identification of its anti-tumour activity, it earned a remarkable place as a treatment of choice for several cancer types. It remains effective against testicular, bladder, lung,...
Saved in:
| Main Author: | Reem Ali (9913494) (author) |
|---|---|
| Other Authors: | Mustapha Aouida (417652) (author), Abdallah Alhaj Sulaiman (18372912) (author), Srinivasan Madhusudan (382058) (author), Dindial Ramotar (208416) (author) |
| Published: |
2022
|
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Successful rechallenge with cisplatin following cisplatin induced ischemic cerebrovascular accident in a patient with small cell lung cancer
by: Farah Rashid (13513911)
Published: (2022) -
Efficacy of Cannabidiol Combination with Cisplatin or Paclitaxel against Platinum-Resistant Ovarian Cancer Cell Lines
by: Ismail, Jana
Published: (2022) -
Targeting of lactate dehydrogenase C dysregulates the cell cycle and sensitizes breast cancer cells to DNA damage response targeted therapy
by: Adviti Naik (673163)
Published: (2021) -
Cisplatin based therapy: the role of the mitogen activated protein kinase signaling pathway
by: Iman W. Achkar (4246141)
Published: (2018) -
The Protective Effects of Daucus carota L. ssp. carota and Cannabis sativa L. Extracts against Cisplatin Induced Nephrotoxicity in Animal Models
by: Al Toufaily, Sahar
Published: (2021)